Michal Kahana
VP
Haematology
Protalix Biotherapeutics
Israel
Biography
Dr. Michal Kahana joined Protalix in 2009 as Vice President for Quality Affairs with years of experience in QA management in the pharmaceutical industry and broad knowledge of GMP, GLP, and GCP requirements. Prior to joining Protalix, she managed the 85-employee quality department at Dexxon, one of Israel’s largest Pharmaceutical companies, where she guided the company through several FDA, European, and Israeli health authorities inspections. Michal holds a DVM degree from the University of Bologna, Italy.
Research Interest
Medical devices
